The Committee For Medicinal Products For Human Use Of The European Medicines Agency Has Recommended Expanding The Approval Of GSK's Jemperli (Dostarlimab) In Combination With Chemotherapy (Carboplatin And Paclitaxel) For First-line Treatment For...

Benzinga18:04

GSK Passes Three Significant Milestones With New Cancer Drug Given a Double Boost | LSE:GSK, NYSE:GSK

Proactive Investors16:18

GSK's Rectal Cancer Treatment Receives Breakthrough Designation From US FDA

MT Newswires15:42

GSK's Cancer Drug Jemperli Moves a Step Closer to European Marketing Permission

WSJ15:37

Jemperli (Dostarlimab) Plus Chemotherapy Receives Positive CHMP Opinion to Expand Approval to All Adult Patients With Primary Advanced or Recurrent Endometrial Cancer

GSK Plc13:00

Jemperli (Dostarlimab) Receives US FDA Breakthrough Therapy Designation for Locally Advanced DMMR/MSI-H Rectal Cancer

GSK Plc13:00